Welcome to Meeting Room 7, a new podcast from Stevens & Bolton.
In this series Charlotte Tillett, Tom Lingard and Tom Collins will be discussing patent and know how licensing in the life sciences sector. In each episode our IP team will look at different aspects of licensing arrangements, from defining the deal to termination and everything in between. We will share practical tips for licensors and licensees on how to negotiate and draft agreements that work, highlight new developments and trends in the sector and...
Welcome to Meeting Room 7, a new podcast from Stevens & Bolton.
In this series Charlotte Tillett, Tom Lingard and Tom Collins will be discussing patent and know how licensing in the life sciences sector. In each episode our IP team will look at different aspects of licensing arrangements, from defining the deal to termination and everything in between. We will share practical tips for licensors and licensees on how to negotiate and draft agreements that work, highlight new developments and trends in the sector and get to the bottom of thorny issues that are often misunderstood.
In this first episode “Defining the deal” we cover:
- Why it is important to spend time agreeing the headline commercial points at the outset of the relationship
- Key issues that may arise when negotiating and defining the scope of the licensed technology (including fields of use, exclusivity and due diligence)
- Considerations concerning the ownership and licensing of improvements (including competition issues)
- Common issues that arise when licensing know how
We would welcome your questions and feedback so let us know if there is anything you would like us to cover in future episodes here.
View more
